The use of medicines as healthcare interventions bring to the fore 2 important aspects of quality namely; ‘quality of medicines’ and ‘quality use of medicines’ (QUM). Governmental and non-governmental agencies in a regulatory and advisory role monitor medicines for quality production, distribution and proper use. Reports about substandard quality medicines suggest a need for further improvements in quality production and distribution of medicines.
Abstract
Share on Mobile
Scan to access on mobile
Keywords
Quality of medicines
Quality use of medicines
Healthcare interventions
Regulatory agencies
Substandard medicines
Content
No content available